In recent studies, Hif1α deletion in NK cells leads to enrichment of the NF-κB pathway in tumor-infiltrating NK cells and promotes INF-1α expression, which leads to slower tumor growth and improved patient OS [92]. The gene discussed is NFKB1; the disease is neoplasm.